Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (8): 1049-1057.doi: 10.12092/j.issn.1009-2501.2025.08.005
Previous Articles Next Articles
ZOU Hong, QI Shuo, LI Dandan, DENG Fangping, CHEN Shuangshuang, FU Shuxin, TANG Zheng, TANGQun
Received:2024-09-16
Revised:2024-10-24
Online:2025-08-26
Published:2025-08-12
CLC Number:
ZOU Hong, QI Shuo, LI Dandan, DENG Fangping, CHEN Shuangshuang, FU Shuxin, TANG Zheng, TANGQun. Hepatotoxicity of Brucea javanica bitter alcohol in nude mice based on liver drug metabolizing enzyme CYP450 expression[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(8): 1049-1057.
| [1] | 国家药典委员会.中华人民共和国药典[M].北京:中国医药科技出版社,2020:266. |
| [2] | 李园香,慕百祥,周锦勇.鸦胆子有效成分抗肿瘤作用机制研究进展[J].江苏中医药, 2024, 56(2):79-82. |
| [3] | 徐水宇,庄怡雪,詹志来,等.鸦胆子的化学成分、药理作用研究进展及其质量标志物的预测分析[J].中国中药杂志,2022,47(19):5158-5170. |
| [4] | Guo SB, Huang WJ, Tian XP. Brusatol modulates diverse cancer hallmarks and signaling pathways as apotential cancer therapeutic[J]. Acta Materia Medica, (3): 278-301. |
| [5] | PanX,Zhou J, Chen Y, et al. Classification, hepatotoxic mechanisms, and targets of the risk ingredients in traditional Chinese medicine-induced liver injury [J].Toxicol Lett, 2020, 323: 48-56. |
| [6] | Björnsson ES. Epidemiology, predisposing factors, and outcomes of drug-induced liver injury[J]. Clin LiverDis, 2020, 24(1): 1-10. |
| [7] | 段晓梦,马心予,白天宇,等.不同药对配伍对栀子引起的肝损伤的保护作用研究[J].中南药学,2023, 21(11): 2901-2907. |
| [8] | Ahmed T, Ahmad J. Recent advances in the diagnosis of drug-induced liver injury [J]. World J Hepatol,2024, 16(2): 186-192. |
| [9] | 叶书林,曾普华,郜文辉,等.八宝丹胶囊联合鸦胆子油乳介入治疗湿热聚毒型原发性肝癌的临床研究[J].湖南中医杂志,2016,32(10):1-4. |
| [10] | Chen Z, He B, Zhao J, et al. Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pathway[J].Phytomedicine, 2022, 104: 154323. |
| [11] | 鄂颖,尚德高,尤胜.苦参碱联合顺铂对人肝癌细胞株HepG2裸鼠移植瘤模型瘤体生长及caspase-3和Survivin 表达的影响[J]. 临床和实验医学杂志,2019, 18(5): 457-460. |
| [12] | 王存萍,罗秋林,沙玉茹,等.中药抗药源性肝损伤评价模型及作用机制研究进展[J].中草药,2023,54(17): 5796-5805. |
| [13] | Shan Y, Zhao J, Wei K, et al. A comprehensive review of Tripterygium wilfordii hook. f. in the treatment of rheumatic and autoimmune diseases: Bioactive com pounds, mechanisms of action, and future directions[J].Front Pharmacol, 2023, 14: 1282610. |
| [14] | 马骏,曼琼,闫潇,等.野生与栽培甘草对马钱子致肝毒性的解毒作用[J].中成药,2023,45(8): 2718-2722. |
| [15] | 钟巨贤,常岸芷,陈博,等.药物性肝损伤的研究进展[J].临床医学研究与实践,2022,7(24):195-198. |
| [16] | Esteves F, Rueff J, Kranendonk M. The central role of cytochrome P450 in xenobiotic metabolism-A brief review on a fascinating enzyme family[J]. J Xenobiot,2021, 11(3): 94-114. |
| [17] | Zhai Q, van der Lee M, van Gelder T, et al. Why we need to take a closer look at genetic contributions to CYP3A activity [J]. Front Pharmacol, 2022, 13:912618. |
| [18] | Zhang RX, Dong K, Wang Z, et al. Nanoparticulate drug delivery strategies to address intestinal cytochrome P450 CYP3A4 metabolism towards personalized medicine[J].Pharmaceutics, 2021, 13(8): 1261. |
| [19] | Lev-Cohain N, Sapir G, Harris T, et al. Real-time ALT and LDH activities determined in viable precision-cut mouse liver slices using hyperpolarized[1- C]pyruvate-Implications for studies on biopsied liver tissues[J].NMR Biomed, 2019, 32(2): e4043. |
| [20] | Martignoni M, Groothuis GMM, Kanter RD. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction[J]. Expert Opin Drug Metab Toxicol, 2006,2(6): 875-894. |
| [1] | Xiaying WANG, Hugang JIANG, Jiakun LIU, Jing MA, Kai LIU, Yingdong LI, Xinke ZHAO. Effect of Angelica astragalus ultrafiltration on cardiomyocytes induced by ionizing radiation and its mechanism [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(3): 300-312. |
| [2] | Xiaomian LIU, Ying LIU, Wenjing TU, Shuo ZHANG, Gaoyan ZHU, Yuyan CUI, Xiaoyu CUI, Yixuan YANG, Xiaobing LI, Hongtao GUO, Dong LI, Xiaojuan HE. Unraveling the molecular mechanisms of modified Er-Miao-San (MEMS) in acute gouty arthritis: a multidisciplinary integration of network pharmacology, molecular docking, and experimental validation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(3): 313-323. |
| [3] | Ke ZHANG, Ziting LI, Fofo JIANG, Feng ZHAO, Yinling MA, Guoxun PANG. Effect of Dan-Lou tablets on the pharmacokinetics and pharmacodynamics of atorvastatin in high-fat diet-fed rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(3): 324-336. |
| [4] | Yajie BAI, Liuqing YANG, Qin FAN, Xuwei LIU, Yuchen HE, Jiamao CHENG, Haiyan CHEN. The anti-hepatic fibrosis mechanism of Dendrobium officinale poly saccharides in vitro through epithelial-mesenchymal transition and Notch signaling pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(3): 337-343. |
| [5] | Weichen WANG, Yaping MA, Meng WANG, Qinglin LI, Hui CHENG. Therapeutic effect of emodin on cholestatic liver injury in mice based on CYP7A1 / FXR / SHP pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(2): 204-212. |
| [6] | Pengfei WANG, Yuwei WANG, Fangmei JIN, Ping CHEN, Weiqing LI, Xuemei TIAN, Aihua WANG, Haidong WANG. The mechanism of action of Yiqi Huoluo formula in regulating the PI3K/Akt/mTOR pathway to suppress synovial inflammation in collagen-induced arthritis rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(2): 213-222. |
| [7] | Dake QI, Jinjing CHE. Overview of PBPK modeling method for transdermal patch delivery [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(2): 223-239. |
| [8] | Zishuai WEN, Shengnan LIANG, Yuling RUAN, Wentao ZHANG, Mengying LI, Fangfang WU, Junhui LIU, Huazhen QIN. Exploring the mechanism of Alpiniae Officinarum Rhizoma and two other Alpinia Roxb medicinal materials in treating gastric ulcer with cold syndrome based on network pharmacology, molecular docking and experimental validation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(1): 28-39. |
| [9] | Tao WANG, Xiaowen CHENG, Zhirui ZHANG, Hao JIAO. Shikonin restrains TGF-β1/Smad signaling pathway to improve renal fibrosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(1): 48-54. |
| [10] | YANG Fan, JIN Liang, CHEN Luyang, LI Lan, ZHOU Haifeng, WU Jing. Mg2+/quercetin-loaded alginate hydrogel exerts immunomodulatory effects by suppressing neutrophil inflammation and oxidative stress [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(12): 1640-1647. |
| [11] | XU Linlin, ZHANG Dou, DING Pengtao, XI Xiaoxia, YANG Pengfei, ZHANG Xiaoya, LI Tingbao. Protective mechanism of Guomin decoction against atopic dermatitis in mice based on TLR4/MyD88/NF-κB signaling pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(12): 1648-1657. |
| [12] | GUO Dandan, HANG Pengzhou, ZHAO Jing, ZHU Hua. 7,8-Dihydroxyflavone exacerbates arsenic trioxide-induced cardiomyocyte toxicity and mitochondrial respiratory dysfunction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(11): 1500-1507. |
| [13] | LIU Zhaofeng, LI Ling, NA Shufang, YUE Jiang, YE Qifa. Establishment and function of a mouse model of renal tubular epithelial cell-specific FXR gene knockout [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(11): 1508-1515. |
| [14] | WEI Lingjie, ZHANG Mingyu, TAO Zhihao, WANG Mengyu, YAN Jingjing, WANG Xinyi, CHAI Lin. Effects of AAVC-I on proliferation and migration of human oral squamous cell carcinoma SCC4 and Cal27 cells through ERK1/2/MAPK signaling pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(11): 1516-1523. |
| [15] |
FU Xiaoyan, GONG Zihan, GAO Guangmiao, YANG Biqian, DENG Yi, WANG Liping, YANG Xiujuan, YANG Zhijun.
Exploring the mechanism of Licorice in the treatment of liver injury induced by Semen Strychni based on network pharmacology, molecular docking and animal experiments
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(10): 1326-1341.
|
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||